Curtana Pharmaceuticals Inc.
Austin, TX
- UEI
- PM1PJ3RUXZ54
- CAGE
- 6WCS9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4200 Marathon Blvd #200, Austin, TX 78756, USA
- Website
- curtanapharma.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Discovery of novel therapeutics for glioblastoma | National Cancer Institute (NIH) | $300,000 | |
| Validation of a novel treatment for glioblastoma | National Institutes of Health | $225,000 |
Quick answers
Is Curtana Pharmaceuticals Inc. registered in SAM.gov?
Yes. Curtana Pharmaceuticals Inc.'s SAM.gov registration is active through December 15, 2026.
What is Curtana Pharmaceuticals Inc.'s most recent federal award?
Curtana Pharmaceuticals Inc.'s most recent federal grant award is Discovery of novel therapeutics for glioblastoma (R43CA213695), from National Cancer Institute (NIH), on September 13, 2017.
On GovTribe
See Curtana Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors